IKK epsilon-KO Dual Reporter THP-1 Cells

NF-κB-SEAP & IRF-Lucia reporter human monocytes - IKKε deficient

SPECIFICATIONS

Specifications

Tested applications

Screening of PRR agonists or inhibitors

Species
Human
Cell type
Monocytic
Growth properties
Suspension
Tissue origin
Human monocytes
Reporter gene
SEAP
Lucia®
Detection method
Colorimetric / Luminescence
Growth medium

Complete RPMI (see TDS)

Antibiotic resistance
Blasticidin
Zeocin®
Mycoplasma-free

Tested and validated using PlasmotestTM.

Quality control

Each lot is functionally tested and validated

CONTENTS

Contents

  • Product: 
    THP1-Dual™ KO-IKKε Cells
  • Cat code: 
    thpd-koikke
  • Quantity: 
    3-7 x 10^6 cells
Includes:
  • 1 ml of Normocin™ (50 mg/ml)
  • 1 ml of Zeocin® (100 mg/ml)
  • 1 ml of Blasticidin (10 mg/ml)
  • 1 tube of QUANTI-Luc™ 4 Reagent (sufficient to prepare 25 ml)
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml)

Shipping & Storage

  • Shipping method:  Dry ice
  • Storage:

    • Liquid nitrogen vapor
    Stability: 20 passages

Details

IKKε Background

‘IKK-related kinases IκB kinase ε’ (IKKɛ), also known as IKK-inducible or IKK-i, is an IKK-related kinase. IKKɛ is highly similar to the other reported IKK-related kinase, TANK binding kinase 1 (TBK1), and both play an essential role in the innate immune response to bacterial and viral pathogens. Notably, their roles and signaling pathways are highly intertwined (i.e. IKKɛ/TBK1), thus there remain many uncertainties about their individual functions [1-3]. However, it is clear that they act downstream of a number of pattern recognition receptors (PRRs) such as the DNA-sensing cGAS, the RNA‑sensing RIG-I, as well as TLRs (e.g. TLR3 & TLR4). Ultimately, the stimulation of these PRRs activates IKKɛ/TBK1 promoting the induction of pro-inflammatory cytokines and interferons (IFNs) through the phosphorylation of NF-ĸB (i.e.p65) or interferon regulatory factors (IRF3 and IRF7), respectively [1, 3]. Activation of IKKɛ/TBK1 requires the binding of different scaffold proteins (TANK, NAP1, SINTBAD), which allow them to mediate their various phosphorylation activities [1, 3]. Interestingly, studies focusing on IKKɛ in particular, highlight an important role in the development of inflammatory diseases (e.g. Rheumatoid arthritis) [3]. Furthermore, IKKɛ is considered an oncogene due to its implication in multiple cancers [2, 3]. Thus, IKKɛ is considered a potential therapeutic target in the clinic.  

 

References:

1. Chau, T.L. et al. 2008. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated? Trends Biochem Sci 33, 171-180.
2. Clement, J.F. et al. 2008. The IKK-related kinases: from innate immunity to oncogenesis. Cell Res 18, 889-899.
3. Verhelst, K. et al. 2013. IkappaB kinase epsilon (IKKepsilon): a therapeutic target in inflammation and cancer. Biochem Pharmacol 85, 873-880.

DOCUMENTS

Documents

THP1-Dual™ KO-IKKε Cells

Technical Data Sheet

Validation Data Sheet

Safety Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?